Preventing heart disease by controlling hypertension: impact of hypertensive subtype, stage, age, and sex.
about
Environmental and genetic contribution to hypertension prevalence: data from an epidemiological survey on Sardinian genetic isolates.Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004.Factors associated with hypertension prevalence, unawareness and treatment among Costa Rican elderly.The Canadian Hypertension Education Program (CHEP) recommendations: launching a new series.Age- and gender-specific population attributable risks of metabolic disorders on all-cause and cardiovascular mortality in Taiwan.Temporal trends in the population attributable risk for cardiovascular disease: the Atherosclerosis Risk in Communities Study.Older adults' perception of chronic illness management in South KoreaChanges in the rates of awareness, treatment and control of hypertension in Canada over the past two decades.Prevalence of uncontrolled hypertension in primary care settings in Al seeb wilayat, oman.Living donor practices in the United StatesHyperuricaemia - A Potential Indicator to Diagnose the Risk of Essential Hypertension.Radiation treatment in older patients: a framework for clinical decision making.Prehypertension and hypertension in a primary care practice.Combined therapy with a calcium channel blocker and an angiotensin II type 1 receptor blocker.Management of hypertension in elderly long-term care residentsControversies over the role of radiation therapy for ductal carcinoma in situ.A trend analysis of the prevalence, awareness, treatment, and control of hypertension by age groupPredictors of hypertension awareness, treatment, and control among Mexican American women and menEffectiveness of radiation for prevention of mastectomy in older breast cancer patients treated with conservative surgery.The combined effect of hypertension and smoking on arterial stiffness.The metabolic syndrome in women.Combination polypharmacy for cardiovascular disease prevention in men: a decision analysis and cost-effectiveness model.
P2860
Q30606829-28E662EE-440B-4878-92AB-F2DDA8DA849AQ31154263-3D3BCA6F-D208-4ACD-BAFE-E4812616091FQ33357918-353FF11D-45B3-4BE8-9AF5-16659B96AE1AQ33920612-BE5AC754-3A68-46A0-9161-1675A3F17A31Q34155217-5C496893-AA6A-49CF-9F4D-2D8D8C1963A4Q34169657-CD962183-0726-4D62-9B00-5617A8B87E69Q34170426-26FF69C1-C4C0-43E4-88B1-3C2891EE5C5FQ35044986-77F39784-6DD1-4F20-85EB-2A251FDEFB5AQ35533382-926FD6AD-98EA-4E75-A934-AE7CC77E7B4EQ36062331-3714D3CF-BA7B-457C-B34E-BE2471511C37Q36830972-BB3D7B51-F246-4520-B148-69ED094E417AQ36925147-56FABB38-B9CF-497B-887E-16774644AAAAQ36936509-93E7FEF5-052C-409F-91EC-80FC525A93F7Q37050156-0F1782C7-F713-492F-A639-B9EC61541FD6Q37098520-95EB674B-20FB-42D6-9167-1C3FB2C7B872Q37118950-025EAD68-A8B2-4F2A-9E05-BD2F911EC7C1Q37385081-E013B243-FE62-495A-B10E-B5C7D85F176EQ37392492-D288EA3E-D101-4240-A83D-6E45C2B3F626Q37449553-C22A2A56-073B-4AE4-BEED-660424F19AEDQ37804394-8DFD15EC-9362-4EFC-A774-0711D407498BQ43267027-9DE2E1B7-13A1-47D9-830D-72C808969A7FQ46823637-163C203D-E25B-4AD6-8EF9-4AA3B0FEA81A
P2860
Preventing heart disease by controlling hypertension: impact of hypertensive subtype, stage, age, and sex.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Preventing heart disease by co ...... subtype, stage, age, and sex.
@en
Preventing heart disease by co ...... subtype, stage, age, and sex.
@nl
type
label
Preventing heart disease by co ...... subtype, stage, age, and sex.
@en
Preventing heart disease by co ...... subtype, stage, age, and sex.
@nl
prefLabel
Preventing heart disease by co ...... subtype, stage, age, and sex.
@en
Preventing heart disease by co ...... subtype, stage, age, and sex.
@nl
P2093
P1476
Preventing heart disease by co ...... subtype, stage, age, and sex.
@en
P2093
Gaurav Thakral
Gil J L'Italien
Joanna L Whyte
Milagros J Jacobs
Nathan D Wong
Pablo Lapuerta
Stanley S Franklin
P304
P356
10.1016/S0002-8703(02)94787-3
P407
P577
2003-05-01T00:00:00Z